Detail akcie Tubize online

Business Summary: Financiere de Tubize SA is a Belgium-based holding company. The Company holds minor capital in UCB SA. UCB is a Belgian pharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. UCB, together with its subsidiaries, has research and development facilities in Belgium, Germany, Japan, the United Kingdom and the United States. The Company promotes the development of a sustainable biopharma ecosystem in Belgium and possibly in other geographic areas relevant to UCB.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Financiere de Tubize SA revenues was not reported. Net income increased 3% to EUR93.2M. Net income benefited from Interest Income - Non-Bank increase of 2% to EUR98.1M (income), Interest Exp-Net of Capitalized Interest decrease of 47% to EUR1.8M (expense), Net Financial Income/Expense - Other decrease of 31% to EUR52K (expense). Dividend per share increased from EUR0.73 to EUR0.76.